AAAAAA

   
Results: 1-13 |
Results: 13
REACHING AN OPTIMAL ERYTHROPOIETIN THERAP Y OF HEMODIALYZED PATIENTS BY IRON TREATMENT - WHICH PARAMETERS ARE IMPORTANT
Authors: ASSENMACHER A EISENHAUER T
Citation: A. Assenmacher et T. Eisenhauer, REACHING AN OPTIMAL ERYTHROPOIETIN THERAP Y OF HEMODIALYZED PATIENTS BY IRON TREATMENT - WHICH PARAMETERS ARE IMPORTANT, Nieren- und Hochdruckkrankheiten, 26(1), 1997, pp. 28-33
CYCLOSPORINE-A TROUGH LEVELS CORRELATE WITH SERUM-LIPOPROTEINS AND APOLIPOPROTEINS - IMPLICATIONS FOR THERAPEUTIC DRUG-MONITORING OF CYCLOSPORINE-A
Authors: VONAHSEN N HELMHOLD M SCHUTZ E EISENHAUER T ARMSTRONG VW OELLERICH M
Citation: N. Vonahsen et al., CYCLOSPORINE-A TROUGH LEVELS CORRELATE WITH SERUM-LIPOPROTEINS AND APOLIPOPROTEINS - IMPLICATIONS FOR THERAPEUTIC DRUG-MONITORING OF CYCLOSPORINE-A, Therapeutic drug monitoring, 19(2), 1997, pp. 140-145
ACCUMULATION OF LOVASTATIN, BUT NOT PRAVASTATIN, IN THE BLOOD OF CYCLOSPORINE-TREATED KIDNEY GRAFT PATIENTS AFTER MULTIPLE DOSES
Authors: OLBRICHT C WANNER C EISENHAUER T KLIEM V DOLL R BODDAERT M OGRADY P KREKLER M MANGOLD B CHRISTIANS U
Citation: C. Olbricht et al., ACCUMULATION OF LOVASTATIN, BUT NOT PRAVASTATIN, IN THE BLOOD OF CYCLOSPORINE-TREATED KIDNEY GRAFT PATIENTS AFTER MULTIPLE DOSES, Clinical pharmacology and therapeutics, 62(3), 1997, pp. 311-321
COMPARISON OF PRAVASTATIN AND LOVASTATIN IN RENAL-TRANSPLANT PATIENTSRECEIVING CYCLOSPORINE
Authors: KLIEM V WANNER C EISENHAUER T OLBRICHT CJ DOLL R BODDAERT M OGRADY P KREKLER M MANGOLD B CHRISTIANS U
Citation: V. Kliem et al., COMPARISON OF PRAVASTATIN AND LOVASTATIN IN RENAL-TRANSPLANT PATIENTSRECEIVING CYCLOSPORINE, Transplantation proceedings, 28(6), 1996, pp. 3126-3128
DECREASE IN LIPOPROTEIN(A) AFTER RENAL-TRANSPLANTATION IS RELATED TO THE GLUCOCORTICOID DOSE
Authors: VONAHSEN N HELMHOLD M EISENHAUER T ARMSTRONG VW OELLERICH M
Citation: N. Vonahsen et al., DECREASE IN LIPOPROTEIN(A) AFTER RENAL-TRANSPLANTATION IS RELATED TO THE GLUCOCORTICOID DOSE, European journal of clinical investigation, 26(8), 1996, pp. 668-675
PRAVASTATIN AND LOVASTATIN PHARMACOKINETICS AND PHARMACODYNAMICS IN RENAL-TRANSPLANT PATIENTS RECEIVING CYCLOSPORINE
Authors: OLBRICHT C WANNER C EISENHAUER T CHRISTIANS U KLIEM V OGRADY P BODDAERT M KREKLER M MANGOLD B
Citation: C. Olbricht et al., PRAVASTATIN AND LOVASTATIN PHARMACOKINETICS AND PHARMACODYNAMICS IN RENAL-TRANSPLANT PATIENTS RECEIVING CYCLOSPORINE, Journal of the American Society of Nephrology, 6(3), 1995, pp. 1061-1061
ANAPHYLACTOID REACTIONS DURING HEMODIALYSIS IN SHEEP ARE ASSOCIATED WITH BRADYKININ RELEASE
Authors: KRIETER DH FINK E BONNER G YOU HM EISENHAUER T
Citation: Dh. Krieter et al., ANAPHYLACTOID REACTIONS DURING HEMODIALYSIS IN SHEEP ARE ASSOCIATED WITH BRADYKININ RELEASE, Nephrology, dialysis, transplantation, 10(4), 1995, pp. 509-513
THE HELP-LDL-APHERESIS MULTICENTER STUDY, AN ANGIOGRAPHICALLY ASSESSED TRIAL ON THE ROLE OF LDL-APHERESIS IN THE SECONDARY PREVENTION OF CORONARY HEART-DISEASE .2. FINAL EVALUATION OF THE EFFECT OF REGULAR TREATMENT ON LDL-CHOLESTEROL PLASMA-CONCENTRATIONS AND THE COURSE OF CORONARY HEART-DISEASE
Authors: SCHUFFWERNER P GOHLKE H BARTMANN U BAGGIO G CORTI MC DINSENBACHER A EISENHAUER T GRUTZMACHER P KELLER C KETTNER U KLEOPHAS W KOSTER W OLBRICHT CJ RICHTER WO SEIDEL D SCHOPPENTHAU M SCHLIERF G MARBURGER C ZOLLNER N SUHLER K SCHWANDT P SCHOTTENFELDNAOR J LESCHKE M GRIES FA GOHLKE W BESTEHORN HP BRAUNAGEL K BAUER M HORL WH JUST H MEINERTZ T SCHOLLMEYER P WIELAND H PREVIATO L CREPALDI G ARMSTRONG VW SCHOEPPE W MUCHE R REXER H HILGERS R
Citation: P. Schuffwerner et al., THE HELP-LDL-APHERESIS MULTICENTER STUDY, AN ANGIOGRAPHICALLY ASSESSED TRIAL ON THE ROLE OF LDL-APHERESIS IN THE SECONDARY PREVENTION OF CORONARY HEART-DISEASE .2. FINAL EVALUATION OF THE EFFECT OF REGULAR TREATMENT ON LDL-CHOLESTEROL PLASMA-CONCENTRATIONS AND THE COURSE OF CORONARY HEART-DISEASE, European journal of clinical investigation, 24(11), 1994, pp. 724-732
HEPARIN EXTRACORPOREAL LDL PRECIPITATION (HELP) - AN EFFECTIVE APHERESIS PROCEDURE FOR LOWERING LP(A) LEVELS
Authors: ARMSTRONG VW SCHUFFWERNER P EISENHAUER T HELMHOLD M STIX M SEIDEL D
Citation: Vw. Armstrong et al., HEPARIN EXTRACORPOREAL LDL PRECIPITATION (HELP) - AN EFFECTIVE APHERESIS PROCEDURE FOR LOWERING LP(A) LEVELS, Chemistry and physics of lipids, 67-8, 1994, pp. 315-321
HEPARIN-INDUCED EXTRACORPOREAL LDL PRECIP ITATION AND ACE-INHIBITORS
Authors: SCHUFFWERNER P EISENHAUER T REXER H
Citation: P. Schuffwerner et al., HEPARIN-INDUCED EXTRACORPOREAL LDL PRECIP ITATION AND ACE-INHIBITORS, Deutsche Medizinische Wochenschrift, 118(45), 1993, pp. 1665-1665
REBOUND KINETICS OF COAGULATION-FACTORS AND THEIR INHIBITORS AFTER HELP-LDL-APHERESIS
Authors: SCHUFFWERNER P MORITZ B SCHULZ S EISENHAUER T LANG H
Citation: P. Schuffwerner et al., REBOUND KINETICS OF COAGULATION-FACTORS AND THEIR INHIBITORS AFTER HELP-LDL-APHERESIS, Thrombosis and haemostasis, 69(6), 1993, pp. 1238-1238
HYPERTENSION AFTER KIDNEY-TRANSPLANTATION
Authors: EISENHAUER T
Citation: T. Eisenhauer, HYPERTENSION AFTER KIDNEY-TRANSPLANTATION, Nieren- und Hochdruckkrankheiten, 22(9), 1993, pp. 430-434
AMELIORATION OF LIPID GLOMERULOPATHY BY THE HMG-COA REDUCTASE INHIBITOR LOVASTATIN IN GUINEA-PIGS - AN EFFECT WITHOUT OVERT REDUCTION IN PLASMA-CHOLESTEROL LEVELS
Authors: GRONE HJ MILLER B WALLI AK EISENHAUER T GRONE E SEIDEL D
Citation: Hj. Grone et al., AMELIORATION OF LIPID GLOMERULOPATHY BY THE HMG-COA REDUCTASE INHIBITOR LOVASTATIN IN GUINEA-PIGS - AN EFFECT WITHOUT OVERT REDUCTION IN PLASMA-CHOLESTEROL LEVELS, Kidney international, 44(1), 1993, pp. 249-249
Risultati: 1-13 |